Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Although Queen Bey's looks were amazing, most of them should definitely be reserved for the stage...with the exception of one thing: her velvet over-the-knee boots. Normally, we'd assume they were high-end designer shoes, which would cost us normal girls a fortune, but nope! Beyoncé opted for a pair by lesser-known label, LFL by Lust For Life—and they go for just under $120! While that's obviously still a pretty penny, designers are selling similar styles for nearly 10 times that, so this is actually kind of a good deal.
https://www.yahoo.com/lifestyle/beyonc-just-wore-hottest-boots-160650224.html
nice ... :)
nice... :)
omg... talk about giving your shares away...
The next DCGD
approx 70k shares from .16 and people are giving shares away... wow
I accidentally sold instead of bought....omg. I CAN'T BELIEVE HOW CHEAP THEY ARE.....!
RBNW, RM.. BEAST
that's what they all say, said it about DCGD also... don't buy if you don't want to.
Detailed Information
Location Type Headquarters
Year Established 2014
Annual Revenue Estimate 2416647
Employees 10
SIC Code 3021, Rubber and Plastics Footwear
NAICS Code 316210, Footwear Manufacturing
Business Categories
Protective Footwear, Rubber or Plastic in Teaneck, NJ
Protective Footwear, Rubber or Plastic
Rubber And Plastics Footwear
I agree.
https://www.amtwoundcare.com/overview.html is Gordian Medical
https://www.bloomberg.com/profile/company/9270081Z:US
American Medical Technologies (AMT), a dba of Gordian Medical, Inc., is a senior care company focused on delivering solutions to patients and providers in the long-term care and post-acute environments since 1994. Our post-acute programs deliver wound care, ostomy, urological, tracheostomy ?and specialized laboratory services. AMT is the leading independent provider of wound care solutions for long term care facilities in the United States and our programs service over 6,250 facilities nationwide.
has the address been verified?
ADLI, another 10 SS, .25 GAAP
similar structure to mghl with the tiny floats
Patience PAYS...
.10 par value alone
volume...?
Who is the idiot?
if someone is selling, then someone is buyin :)...
PREVIOUS LAZAR TICKERS THAT HAVE FOUND A REVERSE MERGER PARTNER: (16)
OWVI, RARS(WBWB), DRSX (TEAH), EENX, EQPI(TXCB), MLTC, BESE(FAVO), SYMW(XLWH), LUXI, TNPH, SRDP(BHPA), COHG, NMTT, GNTP, TCPP, EORZ
other lazer shells:
CURRENT LAZAR TICKERS STILL FOR SALE:
SHNL Low OS
HBPE Granted
PEIW Granted
CXCQ Granted Low OS
GLFW Granted
OCBG Granted
TRDX Granted
REPO Granted
IDAD Granted Low OS
FHAI Granted
NTAH Granted
XNNHQ Granted Low OS - 26m O/S
MSHFQ Granted Low OS
CERPQ Granted LOW O/S
ESRG Granted
HIGR Granted
WDIS (a ca. Company)
TTCS (a fla. Company)
WSGF (GRANTED 8/21/2019)
VDPH ( court listed opposition)
USRI (GRANTED)
SIPN (GRANTED)
INNX (GRANTED)
PFMS (GRANTED)
NXPC (GRANTED)
ILXP (GRANTED)
DIEN (court listed opposition)
CRGE (GRANTED)
UNSUCCESSFUL CUSTODIAN ATTEMPTS:
SSYR Initiated SEC suspended due to severely delinquent Financials/Filings
APLD Withdrawn
SNDZ (WITHDRAWN)
this is what is posted above, is it not the correct info??
AMT American Medial Technologies
Welcome to American Medical Technologies
http://amtwoundcare.com/
AMT is an accredited Durable Medical Equipment Prosthetic Orthotic ... and " American Medical Technologies" are trademarks of Gordian Medical, Inc.
COMPANY OVERVIEW
Shares Authorized: 75M / Outstanding: 10.4M / Float: 6.8M
Gordian Medical, Inc., doing business as American Medical Technologies, provides wound care management solutions for long term care facilities in the United States. The company offers wound care management services, including wound evaluation, treatment, and assessment of progress; and wound care programs that include wound care related education and training, clinical support, and risk management to patients in nursing homes. It also supplies durable medical equipment prosthetic orthotics, as well as surgical dressings for pressure ulcers, surgical wounds, vascular and neuropathic ulcers, burns, and other wound etiologies. The company was founded in 1994 and is headquartered in Irvine, California.
http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=118960447
17595 Cartwright Road
Irvine, CA 92614-5847
Phone: (714) 556-0200
https://www.manta.com/c/mr4ht4d/american-medical-technologies
American Medical Technologies Amt
17595 Cartwright Road
Irvine, CA 92614
Phone: (714) 556-0200
Web: www.amtwoundcare.com
American Medical Technologies is a privately held company in Irvine, CA and is a Single Location business.
Categorized under Wholesale Physicians and Surgeons Equipment and Supplies. Our records show it was established in 2007 and incorporated in NV. Current estimates show this company has an annual revenue of 86734922 and employs a staff of approximately 290.
Gabelli Billionaire
https://www.forbes.com/lists/2006/10/454O.html
Mr. McGinity has been President of G.research since 2012. Previously he was a Managing Director, Institutional Sales at Knight Capital Group for fifteen years. Prior to joining Knight, he was an institutional sales trader at Cantor Fitzgerald from 1994-1997; and an equity trader with several wire houses, including Merrill Lynch and Smith Barney. A native of Long Island, New York, Mr. McGinity is a graduate of Villanova University.
In May, the Board of Associated Capital Group formed a special committee to negotiate a transaction between G.research and Morgan Group Holding Co. The transaction remains subject to regulatory approvals and finalizing other conditions for closing. We cannot assure that a transaction will be consummated.
Mr. McGinity was most recently a Managing Director, Institutional Sales at Knight Capital Group for fifteen years. Prior to joining Knight, he was an institutional sales trader at Cantor Fitzgerald from 1994-1997; and an equity trader with several wire houses, including Merrill Lynch and Smith Barney. A native of Long Island, New York, Mr. McGinity is a graduate of Villanova University.
************************************************************************
RYE, N.Y., Oct. 24, 2012 /PRNewswire/ -- Gabelli & Company, Inc., a subsidiary of GAMCO Investors, Inc. (NYSE: GBL), announced today that Cornelius V. McGinity has been appointed as the company's president, effective November 1, 2012. Gabelli & Company, Inc., provides research and trade execution services to hedge funds, mutual funds and other institutional money managers. Mr. McGinity's hiring follows the recent appointment of Daniel M. Miller to Chairman of Gabelli & Company. Previously, Mr. Miller had served as president of the company.
In his new role, Mr. McGinity will help build on Mr. Miller's 10-year successful growth strategy for the business. He will be responsible for all of the firm's institutional research sales and trading initiatives, and is leading the effort to significantly grow the company's client base and team of research analysts. Gabelli & Company, well known for its bottom-up, value-driven approach to equity research, has ranked near the top of the Wall Street Journal's "Best on the Street" survey in each of the past three years.
Mr. McGinity was most recently a Managing Director, Institutional Sales at Knight Capital Group for fifteen years. Prior to joining Knight, he was an institutional sales trader at Cantor Fitzgerald from 1994-1997; and an equity trader with several wire houses, including Merrill Lynch and Smith Barney. A native of Long Island, New York, Mr. McGinity is a graduate of Villanova University.
GAMCO Investors, Inc. (NYSE: GBL), through its subsidiaries, manages assets of private advisory accounts (GAMCO), mutual funds and closed-end funds (Gabelli Funds, LLC), and partnerships and offshore funds (Investment Partnerships) and is known for its Private Market Value with a Catalystâ„¢ style of investment.
gotcha.
150k In a penny??
Management Changes Announced: G.research LLC Announces Management Changes
9:49 am ET August 8, 2019 (BusinessWire) Print
G.research, LLC, a subsidiary of Associated Capital Group, (NYSE: AC), announced today that Vincent M. Amabile, a 16 year veteran, has been named President of G.research, LLC and will become a board member of Morgan Group Holding Co. (OTC: MGHL) with the merger of the two companies. Cornelius V. McGinity has been elevated to the Office of the Chairman of the Company. G.research provides institutional research and trade execution services to hedge funds, mutual funds and other institutional money managers.
Vincent Amabile, a Manhattan resident and graduate of Fairfield University, joined the trading desk of G.research in 2003. Previously, he worked for Herzog Heine Geduld and Merrill Lynch as an equity trader. In his new role, Mr. Amabile will be responsible for all of the firm's institutional research sales and trading initiatives, and will lead the firm's effort to expand the company's client base.
Mr. McGinity has been President of G.research since 2012. Previously he was a Managing Director, Institutional Sales at Knight Capital Group for fifteen years. Prior to joining Knight, he was an institutional sales trader at Cantor Fitzgerald from 1994-1997; and an equity trader with several wire houses, including Merrill Lynch and Smith Barney. A native of Long Island, New York, Mr. McGinity is a graduate of Villanova University.
In May, the Board of Associated Capital Group formed a special committee to negotiate a transaction between G.research and Morgan Group Holding Co. The transaction remains subject to regulatory approvals and finalizing other conditions for closing. We cannot assure that a transaction will be consummated.
About Associated Capital Group, Inc.
The Company operates its investment management business via Gabelli & Company Investment Advisers, Inc. ("GCIA" f/k/a Gabelli Securities, Inc.), its 100% owned subsidiary. GCIA and its wholly-owned subsidiary, Gabelli & Partners, collectively serve as general partners or investment managers to investment funds including limited partnerships, offshore companies and separate accounts. The Company primarily manages assets in equity event-driven strategies, across a range of risk and event arbitrage portfolios and earns management and incentive fees from its advisory activities. GCIA is registered with the Securities and Exchange Commission as an investment advisor under the Investment Advisers Act of 1940, as amended.